Herpesvirus Hominis Infection in Newborn Mice: Treatment with Interferon Inducer Polyinosinic-polycytidylic Acid

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 1975 Jun 11

PMID 1155920

Citations 13

Authors

E R Kern

J C Overall Jr

L A Glasgow

Affiliations

Soon will be listed here.

Abstract

Intranasal inoculation of newborn mice with Herpesvirus hominis (HVH) type 2 provides a model for disseminated herpesvirus infections of human newborn infants. Treatment of this experimental infection with polyinosinic-polycytidylic acid [poly(I:C)] significantly increased the mean survival time and markedly altered the pathogenesis of the infection. No significant protection against final mortality was observed. Poly(I:C) therapy completely inhibited detectable viral replication in all target organs tested except the brain. In the brain there was a 2-day delay in the onset of viral replication in treated animals, which correlated with the 1- to 2-day increase in mean survival time. In general, the control of HVH replication occurred in those target organs in which poly(I:C)-induced interferon was detectable. The failure of poly(I:C) to alter the final mortality of newborn mice infected with HVH appears to be primarily due to the lack of sufficient levels of interferon induced in brain tissue and the failure to prevent viral replication in this critical target organ.

Citing Articles

The mechanism of poly I:C-induced antiviral activity in peritoneal macrophage.

Pyo S Arch Pharm Res. 1994; 17(2):93-9.

PMID: 10319138 DOI: 10.1007/BF02974230.

Early and late pathologic changes in the adrenal glands of mice after infection with herpes simplex virus type 1.

Nachtigal M, CAULFIELD J Am J Pathol. 1984; 115(2):175-85.

PMID: 6372493 PMC: 1900495.

Use of viral infections in animal models to assess changes in the immune system.

Kern E Environ Health Perspect. 1982; 43:71-9.

PMID: 6174323 PMC: 1568886. DOI: 10.1289/ehp.824371.

Adsorption of interferon to homologous and heterologous cells. Brief report.

DeGre M Arch Virol. 1980; 65(1):71-6.

PMID: 6158931 DOI: 10.1007/BF01340543.

Response of cloned progeny of clinical isolates of herpes simplex virus to human leukocyte interferon.

Lazar R, BREINIG M, Armstrong J, Ho M Infect Immun. 1980; 28(3):708-12.

PMID: 6156904 PMC: 551008. DOI: 10.1128/iai.28.3.708-712.1980.

References

Jones B, GALBRAITH J, AL-HUSSAINI M . Vaccinial keratitis treated with interferon. Lancet. 1962; 1(7235):875-9. DOI: 10.1016/s0140-6736(62)91908-6. View

Buckler C, DUBUY H, Johnson M, Baron S . Kinetics of serum interferon response in mice after single and multiple injections of polyI-poly C. Proc Soc Exp Biol Med. 1971; 136(2):394-8. DOI: 10.3181/00379727-136-35272. View

Catalano Jr L, Baron S . Protection against herpes virus and encephalomyocarditis virus encephalitis with a double-stranded RNA inducer of interferon. Proc Soc Exp Biol Med. 1970; 133(2):684-7. DOI: 10.3181/00379727-133-34544. View

Stringfellow D, Glasgow L . Tilorone hydrochloride: an oral interferon-inducing agent. Antimicrob Agents Chemother. 1972; 2(2):73-8. PMC: 444270. DOI: 10.1128/AAC.2.2.73. View

Nahmias A, Alford C, KORONES S . Infection of the newborn with herpesvirus hominis. Adv Pediatr. 1970; 17:185-226. View

Stringfellow D, Glasgow L . Hyporeactivity of infection: potential limitation to therapeutic use of interferon-inducing agents. Infect Immun. 1972; 6(5):743-7. PMC: 422604. DOI: 10.1128/iai.6.5.743-747.1972. View

Allen L, COCHRAN K . Target-organ treatment of neurotropic virus disease with interferon inducers. Infect Immun. 1972; 6(5):819-23. PMC: 422616. DOI: 10.1128/iai.6.5.819-823.1972. View

Stringfellow D, Overall Jr J, Glasgow L . Interferon inducers in therapy of infection with encephalomyocarditis virus in mice. II. Effect of multiple doses of polyriboinosinic-polyribocytidylic acid on viral pathogenesis. J Infect Dis. 1974; 130(5):481-8. DOI: 10.1093/infdis/130.5.481. View

Oh J . Sensitivity of Types 1 and 2 Herpesvirus hominis to an Interferon Inducer, Poly I:C. Infect Immun. 1971; 3(6):847-8. PMC: 416248. DOI: 10.1128/iai.3.6.847-848.1971. View

10.

Glasgow L, Hanshaw J, Merigan T, Petralli J . Interferon and cytomegalovirus in vivo and in vitro. Proc Soc Exp Biol Med. 1967; 125(3):843-9. DOI: 10.3181/00379727-125-32220. View

11.

WHEELER Jr C, HUFFINES W . PRIMARY DISSEMINATED HERPES SIMPLEX OF THE NEWBORN. JAMA. 1965; 191:455-60. DOI: 10.1001/jama.1965.03080060029005. View

12.

HEINEBERG H, Gold E, ROBBINS F . DIFFERENCES IN INTERFERON CONTENT IN TISSUES OF MICE OF VARIOUS AGES INFECTED WITH COXSACKIE B1 VIRUS. Proc Soc Exp Biol Med. 1964; 115:947-53. DOI: 10.3181/00379727-115-29086. View

13.

White J . Fulminating infection with herpes-simplex virus in premature and newborn infants. N Engl J Med. 1963; 269:455-60. DOI: 10.1056/NEJM196308292690906. View

14.

Catalano Jr L, London W, Rice J, Sever J . Prophylactic and therapeutic use of poly(I)-poly(C) (poly-D-lysine) against herpesvirus encephalitis in mice. Proc Soc Exp Biol Med. 1972; 140(1):66-71. DOI: 10.3181/00379727-140-36396. View

15.

Catalano Jr L, Safley G, MUSELES M, Jarzynski D . Disseminated herpesvirus infection in a newborn infant. Virologic, serologic, coagulation, and interferon studies. J Pediatr. 1971; 79(3):393-400. DOI: 10.1016/s0022-3476(71)80146-4. View

16.

Kern E, Overall Jr J, Glasgow L . Herpesvirus hominis infection in newborn mice. I. An experimental model and therapy with iododeoxyuridine. J Infect Dis. 1973; 128(3):290-9. DOI: 10.1093/infdis/128.3.290. View

17.

Park J, Baron S . Herpetic keratoconjunctivitis: therapy with synthetic double-stranded RNA. Science. 1968; 162(3855):811-3. DOI: 10.1126/science.162.3855.811. View

18.

Cathala F, Baron S . Interferon in rabbit brain, cerebrospinal fluid and serum following administration of polyinosinic-polycytidylic acid. J Immunol. 1970; 104(6):1355-8. View

19.

Hamilton L, BABCOCK V, SOUTHAM C . Inhibition of herpes simplex virus by synthetic double-stranded RNA (polyriboadenylic and polyribouridylic acids and polyriboinosinic and polyribocytidylic acids). Proc Natl Acad Sci U S A. 1969; 64(3):878-83. PMC: 223316. DOI: 10.1073/pnas.64.3.878. View

20.

HILLEMAN M . Prospects for the use of double-stranded ribonucleic acid (poly I:C) inducers in man. J Infect Dis. 1970; 121(2):196-211. DOI: 10.1093/infdis/121.2.196. View